Division of Nephrology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Nephrology (Carlton). 2024 Mar;29(3):135-142. doi: 10.1111/nep.14259. Epub 2023 Nov 29.
Vascular and peritoneal access are essential elements for sustainability of chronic dialysis programs. Data on availability, patterns of use, funding models, and workforce for vascular and peritoneal accesses for dialysis at a global scale is limited.
An electronic survey of national leaders of nephrology societies, consumer representative organizations, and policymakers was conducted from July to September 2018. Questions focused on types of accesses used to initiate dialysis, funding for services, and availability of providers for access creation.
Data from 167 countries were available. In 31 countries (25% of surveyed countries), >75% of patients initiated haemodialysis (HD) with a temporary catheter. Seven countries (5% of surveyed countries) had >75% of patients initiating HD with arteriovenous fistulas or grafts. Seven countries (5% of surveyed countries) had >75% of their patients starting HD with tunnelled dialysis catheters. 57% of low-income countries (LICs) had >75% of their patients initiating HD with a temporary catheter compared to 5% of high-income countries (HICs). Shortages of surgeons to create vascular access were reported in 91% of LIC compared to 46% in HIC. Approximately 95% of participating countries in the LIC category reported shortages of surgeons for peritoneal dialysis (PD) access compared to 26% in HIC. Public funding was available for central venous catheters, fistula/graft creation, and PD catheter surgery in 57%, 54% and 54% of countries, respectively.
There is a substantial variation in the availability, funding, workforce, and utilization of vascular and peritoneal access for dialysis across countries regions, with major gaps in low-income countries.
血管通路和腹膜通路是慢性透析项目可持续性的重要因素。关于全球范围内透析血管通路和腹膜通路的可用性、使用模式、融资模式和劳动力的数据有限。
2018 年 7 月至 9 月,对肾脏病学会、消费者代表组织和决策者的国家领导人进行了电子调查。问题集中在开始透析时使用的通路类型、服务资金以及通路创建提供者的可用性。
来自 167 个国家的数据可用。在 31 个国家(调查国家的 25%)中,>75%的患者开始血液透析(HD)时使用临时导管。7 个国家(调查国家的 5%)中>75%的患者开始 HD 时使用动静脉瘘或移植物。7 个国家(调查国家的 5%)中>75%的患者开始 HD 时使用隧道透析导管。57%的低收入国家(LIC)与 5%的高收入国家(HIC)相比,>75%的患者开始 HD 时使用临时导管。91%的 LIC 报告短缺创建血管通路的外科医生,而 46%的 HIC 报告短缺。约 95%的 LIC 参与国报告短缺外科医生进行腹膜透析(PD)通路,而 26%的 HIC 报告短缺。57%、54%和 54%的国家分别为中央静脉导管、瘘管/移植物创建和 PD 导管手术提供公共资金。
各国之间在血管通路和腹膜通路的可用性、资金、劳动力和利用方面存在很大差异,低收入国家存在重大差距。